. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IX Nonalcoholic Fatty Liver (NAFL): Overview S. H. Caldwell, A. Al-Osaimi, C. Chang, C. Davis, E. E.
Inhaltsverzeichnis
Nonalcoholic Fatty Liver (NAFL): Overview. - Role of Leptin in Pathogenesis of NASH. - Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis. - Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH). - Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH. - Clinical Features of Patients with Nonalcoholic Fatty Liver Disease. - Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH). - Mammalian Target of Rapamycin (mTOR). - Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis. - Nutritional Therapy in Patients with Liver Cirrhosis.